Government-certified innovative pharmaceutical firms need to be reborn as research oriented ones

The government has recently selected 43 drug makers as innovative pharmaceutical firms to foster global pharmaceutical firms through the creation of a large-scale R&D fund and offering various tax benefits to local companies.

"The development of new drugs requires large-scale investment but many of our pharmaceutical companies have difficulty in securing the necessary funds. We will expand t...